Back to search results

Liberant™ Thrombectomy System for Blood Clots

This study is gathering information on the Liberant™ Thrombectomy System, a device used to remove fresh, soft blood clots (emboli or thrombi) from blood vessels in the arms and legs. Doctors will share their experiences using the Liberant system in their regular practice. The main goals are to see how safe the device is (rate of serious side effects) and how well it works (technical and procedural success) during the procedure. You might be eligible if you are at least 22 years old and are treated with the Liberant system according to its instructions within 72 hours of your procedure. This study aims to collect information from at least 50 cases.

Study design
This is an observational study where healthcare professionals will report on their experiences using the Liberant system. At least 50 cases will be collected from at least 10 participating healthcare professionals.
What's involved
If you are treated with the Liberant system, your healthcare professional will document their experience with your case within 72 hours of the procedure.
Compensation
Not stated in the trial record.
Follow-up
There is no patient follow-up after the initial procedure data collection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07335341

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Recruiting
Not specifiedAges 22+Observational
Medtronic Endovascular
~50 participants
Updated 2026-08-11 on ClinicalTrials.gov
What's tested:Liberant Thrombectomy System

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of Device related Serious Adverse Event at Index procedure
Measured over Index Procedure
+2 more outcomes measured

Conditions

Venous Embolism of Lower Extremities (Diagnosis)
Arterial Embolism and Thrombosis
Acute DVT of Lower Extremity
Chronic DVT of Lower Extremity
DVT
Deep Vein Thrombosis Leg
Thrombus in the Peripheral Venous Vasculature
Peripheral Arterial Disease
Acute Limb Ischemia
Lower Extremity Acute Limb Ischemia
LE ALI

Explore related trials

Arterial EmbolusDeep Vein ThrombosisLimb ischemiaPeripheral Artery DiseaseVenous Embolism

Where it's being run

4 sites across 4 states
District of Columbia1
Florida1
New York1
Texas1

Study leadership

  • John R Laird Jr, MD · PRINCIPAL_INVESTIGATOR · Medtronic Endovascular

Who to contact

Manasa Gudipally
[email protected]
763-514-4000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Rate of Device related Serious Adverse Event at Index procedureIndex Procedure

    An Adverse Event that converted to Serious Adverse Event, involving the function of the subject device, or the presence of the device in the body, including events that are directly attributable to the Liberant Thrombectomy System

  • Rate of technical success at Index procedureIndex procedure

    Technical success: Successful introduction, delivery, aspiration of fresh, soft emboli or thrombi, and retrieval of the Liberant per the Instructions for Use (IFU) during the index procedure

  • Rate of Procedural Success at Index procedureIndex procedure

    Procedure success: Successful removal of fresh, soft emboli or thrombi and restoration of adequate blood flow, inclusive of all endovascular therapies during the index procedure